OTCMKTS:ZLDPF Zealand Pharma A/S Q1 2025 Earnings Results & Report $35.93 0.00 (0.00%) As of 11/16/2026 12:02 PM Eastern Zealand Pharma A/S beat analyst earnings expectations but missed on revenue in its Q1 2025 results, released May 8, 2025. The company reported EPS of -$0.67 versus the -$0.77 consensus estimate, while revenue of $1.14 million fell short of the $248.61 million estimate by $247.47 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 8, 2025TimeBefore Market Opens Zealand Pharma A/S EPS ResultsActual EPS-$0.67Consensus EPS -$0.77Beat/MissBeat by +$0.10One Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersZealand Pharma A/S Revenue ResultsActual Revenue$1.14 millionExpected Revenue$248.61 millionBeat/MissMissed by -$247.47 millionYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Zealand Pharma A/S Q1 2025 Earnings FAQ Did Zealand Pharma A/S beat earnings estimates for Q1 2025? Zealand Pharma A/S (OTCMKTS:ZLDPF) reported earnings of -$0.67 per share for Q1 2025, beating the consensus estimate of -$0.77. The report was announced on Thursday, May 8, 2025. What was Zealand Pharma A/S' revenue for Q1 2025? Zealand Pharma A/S reported revenue of $1.14 million for Q1 2025, against a consensus estimate of $248.61 million. Zealand Pharma A/S Earnings HeadlinesZealand Pharma A/S (ZLDPF) - What Are Investment Firms Saying About This Stock?November 17 at 2:23 AM | americanbankingnews.comZealand Pharma Earnings Call Signals Strong Pipeline MomentumNovember 15 at 7:05 AM | theglobeandmail.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.November 17 at 1:00 AM | Profits Run (Ad)Transcript : Zealand Pharma A/S, Q3 2026 Earnings Call, Nov 12, 2026November 12, 2026 | marketscreener.comMZealand outlines net $400M Roche cash inflow in Q4 while narrowing 2026 opex to DKK 2.7B-3.0BNovember 12, 2026 | seekingalpha.comZealand Pharma A/S Q3 Loss DeclinesNovember 12, 2026 | rttnews.comSee More Zealand Pharma A/S Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Zealand Pharma A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zealand Pharma A/S and other key companies, straight to your email. Email Address About Zealand Pharma A/SZealand Pharma A/S (OTCMKTS:ZLDPF) is a biotechnology company headquartered in Copenhagen, Denmark. Founded in 1998, it discovers and develops peptide-based medicines, with a focus on metabolic diseases and rare conditions. The company’s portfolio has included Zegalogue (dasiglucagon), an injectable treatment approved in the United States for severe hypoglycemia in people with diabetes. Zealand also develops investigational medicines for areas such as obesity, liver disease and rare gastrointestinal disorders, and works with pharmaceutical partners to advance and commercialize selected programs. Zealand Pharma serves international markets through its development and commercial partnerships. Adam Steensberg has served as the company’s president and chief executive officer.View Zealand Pharma A/S ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.